GLP-1 vs Ozempic
GLP-1 is a drug class. Ozempic is a brand name. Understanding this distinction helps you navigate the growing world of weight loss and diabetes medications.
Key Insight
Ozempic IS a GLP-1 agonist. It contains semaglutide, which mimics the GLP-1 hormone. Other GLP-1s include Wegovy, Mounjaro, and Zepbound.
GLP-1 Medications Explained
Semaglutide (Novo Nordisk)
- • FDA approved for diabetes
- • Weekly injection
- • Off-label for weight loss
Semaglutide (Novo Nordisk)
- • Same drug as Ozempic
- • Higher dose
- • FDA approved for weight loss
Tirzepatide (Eli Lilly)
- • GLP-1 + GIP dual agonist
- • Often more effective
- • Weekly injection
Tirzepatide (Eli Lilly)
- • Same drug as Mounjaro
- • FDA approved for obesity
- • Newer to market
How GLP-1 Agonists Work
1. Appetite Suppression
GLP-1 signals to your brain that you're full, reducing hunger and cravings significantly.
2. Slowed Gastric Emptying
Food stays in your stomach longer, keeping you satisfied with smaller portions.
3. Insulin Regulation
Helps your body produce insulin more efficiently, improving blood sugar control.
4. Reduced Reward Response
May decrease the pleasure response from food, making it easier to resist overeating.
Medical Disclaimer
GLP-1 medications require a prescription. They have side effects including nausea, constipation, and potential thyroid concerns. Always consult a healthcare provider.